The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Chemical modification and design of anti-miRNA oligonucleotides
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Small silencing RNAs: an expanding universe
Ghildiyal, M., & Zamore, P. D. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2504 · Cited by 2,325
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
Targeting microRNAs in cancer: rationale, strategies and challenges
Garzon, R., Marcucci, G., & Croce, C. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3179 · Cited by 1,493
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
Morpholino Antisense Oligomers: Design, Preparation, and Properties
SUMMERTON, J., & WELLER, D. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.187 · Cited by 1,116
MicroRNA-143 Regulates Adipocyte Differentiation
Esau, C., Kang, X., Peralta, E., Hanson, E., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400438200 · Cited by 1,021
Antisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
Freier, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.22.4429 · Cited by 692
Elmén, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., Hedtjärn, M., Hansen, J. B., Hansen, H. F., Straarup, E. M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1113 · Cited by 672
Silencing of microRNA families by seed-targeting tiny LNAs
Obad, S., dos Santos, C. O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.786 · Cited by 627
Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing
MEISTER, G., LANDTHALER, M., DORSETT, Y., & TUSCHL, T. (2004) · RNA · doi:10.1261/rna.5235104 · Cited by 621
LNA: a versatile tool for therapeutics and genomics
Petersen, M., & Wengel, J. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)00038-0 · Cited by 613
Sequence-specific inhibition of small RNA function
Hutvágner, G., Simard, M. J., Mello, C. C., & Zamore, P. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020098 · Cited by 584
The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation
Naguibneva, I., Ameyar-Zazoua, M., Polesskaya, A., Ait-Si-Ali, S., Groisman, R., Souidi, M., Cuvellier, S., & Harel-Bellan, A. (2006) · Nature Cell Biology · doi:10.1038/ncb1373 · Cited by 578
A Primer for Morpholino Use in Zebrafish
Bill, B. R., Petzold, A. M., Clark, K. J., Schimmenti, L. A., & Ekker, S. C. (2009) · Zebrafish · doi:10.1089/zeb.2008.0555 · Cited by 474
Specificity, duplex degradation and subcellular localization of antagomirs
Krützfeldt, J., Kuwajima, S., Braich, R., Rajeev, K. G., Pena, J., Tuschl, T., Manoharan, M., & Stoffel, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm024 · Cited by 455
Chemical Modification of siRNAs for In Vivo Use
Behlke, M. A. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0164 · Cited by 454
Self-citationImproved targeting of miRNA with antisense oligonucleotides
Davis, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl183 · Cited by 422
LNA-modified oligonucleotides mediate specific inhibition of microRNA function
Ørom, U. A., Kauppinen, S., & Lund, A. H. (2006) · Gene · doi:10.1016/j.gene.2005.12.031 · Cited by 373
miRNA malfunction causes spinal motor neuron disease
Haramati, S., Chapnik, E., Sztainberg, Y., Eilam, R., Zwang, R., Gershoni, N., McGlinn, E., Heiser, P. W., Wills, A.-M., Wirguin, I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006151107 · Cited by 327
Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections
Obernosterer, G., Martinez, J., & Alenius, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.153 · Cited by 327
Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate
Flynt, A. S., Li, N., Thatcher, E. J., Solnica-Krezel, L., & Patton, J. G. (2007) · Nature Genetics · doi:10.1038/ng1953 · Cited by 326
EDER, P. S., DeVINE, R. J., DAGLE, J. M., & WALDER, J. A. (1991) · Antisense Research and Development · doi:10.1089/ard.1991.1.141 · Cited by 293
Melkman‐Zehavi, T., Oren, R., Kredo‐Russo, S., Shapira, T., Mandelbaum, A. D., Rivkin, N., Nir, T., Lennox, K. A., Behlke, M. A., Dor, Y., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.361 · Cited by 280
Self-citationLocked Nucleic Acid (LNA) Recognition of RNA: NMR Solution Structures of LNA:RNA Hybrids
Petersen, M., Bondensgaard, K., Wengel, J., & Jacobsen, J. P. (2002) · Journal of the American Chemical Society · doi:10.1021/ja012288d · Cited by 264
Fabani, M. M., & Gait, M. J. (2008) · RNA · doi:10.1261/rna.844108 · Cited by 252
Silahtaroglu, A. N., Nolting, D., Dyrskjøt, L., Berezikov, E., Møller, M., Tommerup, N., & Kauppinen, S. (2007) · Nature Protocols · doi:10.1038/nprot.2007.313 · Cited by 227
Efficient inhibition of miR-155 function in vivo by peptide nucleic acids
Fabani, M. M., Abreu-Goodger, C., Williams, D., Lyons, P. A., Torres, A. G., Smith, K. G. C., Enright, A. J., Gait, M. J., & Vigorito, E. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq160 · Cited by 214
Vivo-Morpholinos: A Non-Peptide Transporter Delivers Morpholinos into a Wide Array of Mouse Tissues
Morcos, P. A., Li, Y., & Jiang, S. (2008) · BioTechniques · doi:10.2144/000113005 · Cited by 203
Potent inhibition of microRNA in vivo without degradation
Davis, S., Propp, S., Freier, S. M., Jones, L. E., Serra, M. J., Kinberger, G., Bhat, B., Swayze, E. E., Bennett, C. F., & Esau, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn904 · Cited by 200
Worm, J., Stenvang, J., Petri, A., Frederiksen, K. S., Obad, S., Elmén, J., Hedtjärn, M., Straarup, E. M., Hansen, J. B., & Kauppinen, S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp577 · Cited by 192
A Direct Comparison of Anti-microRNA Oligonucleotide Potency
Lennox, K. A., & Behlke, M. A. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0156-0 · Cited by 182
Self-citationImprovement through novel chemical modifications
Kurreck, J. (2003) · Cited by 179
Boutla, A., Delidakis, C., & Tabler, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg707 · Cited by 143
Santhakumar, D., Forster, T., Laqtom, N. N., Fragkoudis, R., Dickinson, P., Abreu‐Goodger, C., Manakov, S. A., Choudhury, N. R., Griffiths, S. J., Vermeulen, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008861107 · Cited by 116
miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate
Mann, M., Barad, O., Agami, R., Geiger, B., & Hornstein, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915022107 · Cited by 111
Double-stranded regions are essential design components of potent inhibitors of RISC function
Vermeulen, A., Robertson, B., Dalby, A. B., Marshall, W. S., Karpilow, J. M., Leake, D., Khvorova, A., & Baskerville, S. (2007) · RNA · doi:10.1261/rna.448107 · Cited by 103
Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity
Tang, J. Y., Temsamani, J., & Agrawal, S. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.11.2729 · Cited by 93
Torres, A. G., Fabani, M., Vigorito, E., & Gait, M. (2011) · RNA: A publication of the RNA Society · doi:10.1261/rna.2533811 · Cited by 91
Specificity and functionality of microRNA inhibitors
Robertson, B., Dalby, A. B., Karpilow, J. M., Khvorova, A., Leake, D., & Vermeulen, A. (2010) · Silence · doi:10.1186/1758-907x-1-10 · Cited by 81
Characterization of Modified Antisense Oligonucleotides in Xenopus laevis Embryos
Lennox, K. A., Sabel, J. L., Johnson, M. J., Moreira, B. G., Fletcher, C. A., Rose, S. D., Behlke, M. A., Laikhter, A. L., Walder, J. A., & Dagle, J. M. (2006) · Oligonucleotides · doi:10.1089/oli.2006.16.26 · Cited by 51
Self-citation
Cited by
Lu, T. X., & Rothenberg, M. E. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.034 · Cited by 2,425
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Ling, H., Fabbri, M., & Calin, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4140 · Cited by 1,465
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,033
Metadata
- Authors
- Lennox, K. A., & Behlke, M. A.
- Venue
- Gene Therapy
- Published
- 2011-07-14
- Volume
- 18
- Issue
- 12
- Pages
- 1111-1120
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W1966868778
- Cited by
- 433
- References
- 49
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.